EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudiePragmatische Studie

Endovascular treatment of brain arteriovenous malformations: clinical outcomes of patients included in the registry of a pragmatic randomized trial

Jean Raymond, Jean-Christophe Gentric, Elsa Magro, Lorena Nico, Emma Bacchus, Ruby Klink, Christophe Cognard, Anne-Christine Januel, Jean-François Sabatier, Daniela Iancu, Alain Weill, Daniel Roy und 34 weitere

Journal of Neurosurgery · 01.05.2023 · 138 (5) · 1393-1402

DOI: 10.3171/2022.9.jns22987 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Neurosurgery, erschienen am 01.05.2023. Verfasst von Jean Raymond und 45 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Radiology, Service of Neuroradiology, Centre hospitalier de l'Université de Montréal (CHUM), and CHUM Research Centre, Montréal, Québe…. Hauptthemen laut MEDLINE: Intracranial Arteriovenous Malformations, Embolization, Therapeutic, Radiosurgery. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE The role of endovascular treatment in the management of patients with brain arteriovenous malformations (AVMs) remains uncertain. AVM embolization can be offered as stand-alone curative therapy or prior to surgery or stereotactic radiosurgery (SRS) (pre-embolization). The Treatment of Brain AVMs Study (TOBAS) is an all-inclusive pragmatic study that comprises two randomized trials and multiple registries. METHODS Results from the TOBAS curative and pre-embolization registries are reported. The primary outcome for this report is death or dependency (modified Rankin Scale [mRS] score > 2) at last follow-up. Secondary outcomes include angiographic results, perioperative serious adverse events (SAEs), and permanent treatment-related complications leading to an mRS score > 2. RESULTS From June 2014 to May 2021, 1010 patients were recruited in TOBAS. Embolization was chosen as the primary curative treatment for 116 patients and pre-embolization prior to surgery or SRS for 92 patients. Clinical and angiographic outcomes were available in 106 (91%) of 116 and 77 (84%) of 92 patients, respectively. In the curative embolization registry, 70% of AVMs were ruptured, and 62% were low-grade AVMs (Spetzler-Martin grade I or II), while the pre-embolization registry had 70% ruptured AVMs and 58% low-grade AVMs. The primary outcome of death or disability (mRS score > 2) occurred in 15 (14%, 95% CI 8%–22%) of the 106 patients in the curative embolization registry (4 [12%, 95% CI 5%–28%] of 32 unruptured AVMs and 11 [15%, 95% CI 8%–25%] of 74 ruptured AVMs) and 9 (12%, 95% CI 6%–21%) of the 77 patients in the pre-embolization registry (4 [17%, 95% CI 7%–37%] of 23 unruptured AVMs and 5 [9%, 95% CI 4%–20%] of 54 ruptured AVMs) at 2 years. Embolization alone was confirmed to occlude the AVM in 32 (30%, 95% CI 21%–40%) of the 106 curative attempts and in 9 (12%, 95% CI 6%–21%) of 77 patients in the pre-embolization registry. SAEs occurred in 28 of the 106 attempted curative patients (26%, 95% CI 18%–35%, including 21 new symptomatic hemorrhages [20%, 95% CI 13%–29%]). Five of the new hemorrhages were in previously unruptured AVMs (n = 32; 16%, 95% CI 5%–33%). Of the 77 pre-embolization patients, 18 had SAEs (23%, 95% CI 15%–34%), including 12 new symptomatic hemorrhages [16%, 95% CI 9%–26%]). Three of the hemorrhages were in previously unruptured AVMs (3/23; 13%, 95% CI 3%–34%). CONCLUSIONS Embolization as a curative treatment for brain AVMs was often incomplete. Hemorrhagic complications were frequent, even when the specified intent was pre-embolization before surgery or SRS. Because the role of endovascular treatment remains uncertain, it should preferably, when possible, be offered in the context of a randomized trial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intracranial Arteriovenous MalformationsEmbolization, TherapeuticRadiosurgeryHumansTreatment OutcomeRegistriesBrainRetrospective Studies

Stichwörter der Autor:innen

brain arteriovenous malformationcare trialendovascular neurosurgeryendovascular treatment registryrandomized trialruptured AVMunruptured AVMvascular disorders

Autor:innen und Institutionen

  • 1Department of Radiology, Service of Neuroradiology, Centre hospitalier de l'Université de Montréal (CHUM), and CHUM Research Centre, Montréal, Québec, Canada.
  • 2Department of Radiology, CHU Cavale Blanche, GETBO UMR 1034, Brest, France.
  • 3Department of Neurosurgery, CHU Cavale Blanche, INSERM UMR 1101 LaTIM, Brest, France.
  • 4Department of Radiology, CHU Saint-Etienne, France.
  • 5Division of Neurosurgery, Department of Surgery, University of Alberta Hospital, Mackenzie Health Sciences Centre, Edmonton, Alberta, Canada.
  • Departments of6Neuroradiology and.

Zitieren

APA

Raymond, J., Gentric, J. C., Magro, E., Nico, L., Bacchus, E., Klink, R., Cognard, C., Januel, A. C., Sabatier, J. F., Iancu, D., Weill, A., Roy, D., Bojanowski, M. W., Chaalala, C., Barreau, X., Jecko, V., Papagiannaki, C., Derrey, S., Shotar, E., …, & Collaborators in the TOBAS Collaborative Group (2023). Endovascular treatment of brain arteriovenous malformations: clinical outcomes of patients included in the registry of a pragmatic randomized trial. Journal of Neurosurgery, 138(5), 1393-1402. https://doi.org/10.3171/2022.9.jns22987

Vancouver

Raymond J, Gentric JC, Magro E, Nico L, Bacchus E, Klink R, et al. Endovascular treatment of brain arteriovenous malformations: clinical outcomes of patients included in the registry of a pragmatic randomized trial. Journal of Neurosurgery. 2023;138(5):1393-1402. doi:10.3171/2022.9.jns22987

BibTeX
@article{Raymond2023,
  author = {Raymond, Jean and Gentric, Jean-Christophe and Magro, Elsa and Nico, Lorena and Bacchus, Emma and Klink, Ruby and Cognard, Christophe and Januel, Anne-Christine and Sabatier, Jean-François and Iancu, Daniela and Weill, Alain and Roy, Daniel and Bojanowski, Michel W and Chaalala, Chiraz and Barreau, Xavier and Jecko, Vincent and Papagiannaki, Chrysanthi and Derrey, Stéphane and Shotar, Eimad and Cornu, Philippe and Eker, Omer F and Pelissou-Guyotat, Isabelle and Piotin, Michel and Aldea, Sorin and Beaujeux, Rémy and Proust, François and Anxionnat, René and Costalat, Vincent and Corre, Marine Le and Gauvrit, Jean-Yves and Morandi, Xavier and Brunel, Hervé and Roche, Pierre-Hugues and Graillon, Thomas and Chabert, Emmanuel and Herbreteau, Denis and Desal, Hubert and Trystram, Denis and Barbier, Charlotte and Gaberel, Thomas and Nguyen, Thanh N and Viard, Geraldine and Gevry, Guylaine and Darsaut, Tim E and TOBAS Collaborative Group, TOBAS Collaborative Group and Collaborators in the TOBAS Collaborative Group, Collaborators in the TOBAS Collaborative Group},
  title = {Endovascular treatment of brain arteriovenous malformations: clinical outcomes of patients included in the registry of a pragmatic randomized trial},
  journal = {Journal of Neurosurgery},
  year = {2023},
  volume = {138},
  number = {5},
  pages = {1393--1402},
  doi = {10.3171/2022.9.jns22987}
}
Kostenlos starten →